Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CONNECT: Smoking Cessation and Lung Cancer Screening

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04149249
Recruitment Status : Recruiting
First Posted : November 4, 2019
Last Update Posted : November 4, 2019
Sponsor:
Collaborators:
Tobacco Related Disease Research Program
San Francisco Veterans Affairs Medical Center
Information provided by (Responsible Party):
University of California, San Francisco

Brief Summary:
This clinical trial studies the impact of CONNECT on biochemically confirmed smoking abstinence among diverse current smokers who are undergoing lung cancer screening.

Condition or disease Intervention/treatment Phase
Smoking Cessation Other: Computer-Assisted Intervention Video Doctor Other: Computer-Assisted Intervention no Video Doctor Not Applicable

Detailed Description:
The study team will develop and test a novel smoking cessation intervention, CONNECT, which will start at the time an individual is receiving lung cancer screening (LCS). CONNECT will include an interactive Video Doctor which will provide participants with information tailored to their individual responses as well as proactive outreach using brief telephone calls and text messaging to follow up smokers with motivation enhancement to refer and engage patients in evidence based smoking cessation interventions (such as quitline utilization). After development and usability testing, we will conduct a small feasibility study followed by a pilot randomized controlled trial to estimate the impact of CONNECT on biochemically confirmed 30-day smoking abstinence among diverse current smokers seen at the San Francisco Veterans Affairs Medical Center and the University of California San Francisco Division of General Internal Medicine. Participants will be randomized to CONNECT or a control condition. Data will include self-report from participants obtained at baseline, 1 and 3 months, and the electronic health record. Outcomes will be biochemically confirmed 30-day smoking abstinence at 3 months post LCS and satisfaction as well as self-reported quit attempts, and use of evidence-based smoking cessation resources (quitline, pharmacotherapy or counseling). The knowledge gained will provide the pilot data necessary to apply for a larger study to test our novel intervention for promoting smoking cessation among a diverse population of high-risk smokers undergoing Lung Cancer Screening.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 128 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Other
Official Title: CONNECT: Smoking Cessation and Lung Cancer Screening
Actual Study Start Date : August 21, 2019
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : June 30, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Experimental: Intervention Group (CONNECT)
Patients complete CONNECT, the Video Doctor over 30-45 minutes on an iPad in the waiting room before their lung cancer screening test appointment.
Other: Computer-Assisted Intervention Video Doctor
Complete CONNECT: participants will undergo in-person assessment questions and follow-up assessment questions. They will view and participate in the interactive Video Doctor about Smoking Cessation.

Active Comparator: Control Group

Patients complete CONNECT assessment only over 30-45 minutes on an iPad in the waiting room before their lung cancer screening test appointment.

Individuals who are randomized to the control group will undergo the same assessment questions and all follow up assessments like the intervention group. Instead of viewing and participating in the interactive Video Doctor about Smoking Cessation, they receive a handout containing smoking cessation resources.

Other: Computer-Assisted Intervention no Video Doctor
Individuals who are randomized to the control group will undergo the same assessment questions and all follow up assessments like the intervention group. Instead of viewing and participating in the interactive Video Doctor about Smoking Cessation, they receive a handout containing smoking cessation resources.




Primary Outcome Measures :
  1. Assessing 30-day smoking abstinence at 3 months post lung cancer screening. [ Time Frame: Three months from date of lung cancer screening appointment. ]
    The primary outcome will be biochemically confirmed 30-day smoking abstinence at 3 months post lung cancer screening.

  2. Self-reported smoking behavior changes [ Time Frame: Three months from date of lung cancer screening appointment. ]
    Additional outcomes will include self-reported quit attempts, use of evidence-based smoking cessation resources (quitline, pharmacotherapy or counseling).


Secondary Outcome Measures :
  1. Analyzing statistics of frequency counts and proportions of the feasibility measures. [ Time Frame: Baseline up to 18 months. ]
    The secondary outcomes will be descriptive statistics of frequency counts and proportions of the feasibility measures (participation rate, intervention component completion rates), including those who decline to participate and who drop out. The feasibility and acceptability data will be compared between the two groups (intervention and control) using the appropriate general linear models with generalized estimating equations (GEE) to account for provider clusters.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   55 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 55-80
  • Male or female
  • English speaking
  • Have an already scheduled low-dose computed tomography (LDCT) visit
  • Smoke at least 1 cigarette in the last 7 days
  • Have a phone that can receive text messages.

Exclusion Criteria:

  • Younger than 55 or older than 80
  • Does not speak English
  • Does not have a scheduled low-dose computed tomography (LDCT) visit
  • Does not smoke at least 1 cigarette in the last 7 days
  • Does not have a phone that can receive text messages.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04149249


Locations
Layout table for location information
United States, California
UCSF Medical Center-Mount Zion Recruiting
San Francisco, California, United States, 94115
Contact: Judith M. Walsh    415-353-9747    judith.walsh@ucsf.edu   
Principal Investigator: Judith M. Walsh         
San Francisco Veterans Affairs Medical Center Recruiting
San Francisco, California, United States, 94122
Contact: James Brown, MD    415-221-4810    james.brown@ucsf.edu   
Contact: Neil Trivedi, MD    415-221-4810    Neil.Trivedi@ucsf.edu   
Sponsors and Collaborators
University of California, San Francisco
Tobacco Related Disease Research Program
San Francisco Veterans Affairs Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Judith Walsh, MD, MPH UCSF Professor, Division of General Internal Medicine

Publications:
Layout table for additonal information
Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT04149249     History of Changes
Other Study ID Numbers: 18-25632
First Posted: November 4, 2019    Key Record Dates
Last Update Posted: November 4, 2019
Last Verified: October 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University of California, San Francisco:
quitting
smoking
smoking cessation tool
smoking cessation
quit smoking
smoking cessation resources
smoking cessation barriers
smoking cessation intervention tool